Inter J Stomatol ›› 2018, Vol. 45 ›› Issue (3): 346-350.doi: 10.7518/gjkq.2018.03.019

• Reviews • Previous Articles     Next Articles

Development of calcium phosphate scaffolds as drug delivery system in bone tissue engineering

Zhang Yixin, Li Lei   

  1. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Prosthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
  • Received:2017-07-20 Revised:2018-01-13 Published:2018-05-08
  • Supported by:
    This study was supported by National Natural Science Foundation of China (81300857).

Abstract: Calcium phosphates caffolds, especially hydroxyapatite and tricalcium phosphate, have recently attracted researchers’ attention for their use as drug delivery vehicledue to their excellent biocompatibility and bioactivity, which extends a new dimension to their applications. The development of calcium phosphate scaffolds prepared as drug delivery system in bone tissue engineering including its properties, release kinetics, and some of the current drug and growth factor delivery approaches were reviewed.

Key words: bone tissue engineering, calcium phosphates, scaffolds, drug delivery system

CLC Number: 

  • R783

TrendMD: 
[1] Li Y, Xiao Y, Liu C.The horizon of materiobiology: a perspective on material-guided cell behaviors and tissue engineering[J]. Chem Rev, 2017, 117(5):4376-4421.
[2] Oshiro JA, Sato MR, Scardueli CR, et al.Bioactive molecule-loaded drug delivery systems to optimize bone tissue repair[J]. Curr Protein Pept Sci, 2017, 18(8):850-863.
[3] Bose S, Tarafder S.Calcium phosphate ceramic sys-tems in growth factor and drug delivery for bone tissue engineering: a review[J]. Acta Biomaterialia, 2012, 8(4):1401-1421.
[4] Samavedi S, Whittington AR, Goldstein AS.Calcium phosphate ceramics in bone tissue engineering: a review of properties and their influence on cell beha-vior[J]. Acta Biomater, 2013, 9(9):8037-8045.
[5] Denry I, Kuhn LT.Design and characterization of calcium phosphate ceramic scaffolds for bone tissue engineering[J]. Dent Mater, 2016, 32(1):43-53.
[6] Verron E, Bouler JM, Guicheux J.Controlling the biological function of calcium phosphate bone sub-stitutes with drugs[J]. Acta Biomater, 2012, 8(10): 3541-3551.
[7] Sun H, Yang HL.Calcium phosphate scaffolds com-bined with bone morphogenetic proteins or mesen-chymal stem cells in bone tissue engineering[J]. Chin Med J, 2015, 128(8):1121-1127.
[8] Li J, Baker BA, Mou X, et al.Biopolymer/Calcium phosphate scaffolds for bone tissue engineering[J]. Adv Healthc Mater, 2014, 3(4):469-484.
[9] Zhang J, Liu W, Schnitzler V, et al.Calcium phos-phate cements for bone substitution: chemistry, handling and mechanical properties[J]. Acta Bio-mater, 2014, 10(3):1035-1049.
[10] Bose S, Suguira S, Bandyopadhyay A.Processing of controlled porosity ceramic structures via fused de-position[J]. Scripta Materialia, 1999, 41(9):1009-1014.
[11] Lin K, Wu C, Chang J.Advances in synthesis of cal-cium phosphate crystals with controlled size and shape[J]. Acta Biomater, 2014, 10(10):4071-4102.
[12] Tajbakhsh S, Hajiali F.A comprehensive study on the fabrication and properties of biocomposites of poly(lactic acid)/ceramics for bone tissue engineering[J]. Mater Sci Eng C Mater Biol Appl, 2017, 70(Pt 1): 897-912.
[13] Huang GS, Tseng CS, Linju Yen B, et al.Solid free- form-fabricated scaffolds designed to carry multi-cellular mesenchymal stem cell spheroids for cartilage regeneration[J]. Eur Cell Mater, 2013, 26:179-194.
[14] Shanjani Y, Hu Y, Toyserkani E, et al.Solid free-form fabrication of porous calcium polyphosphate structures for bone substitute applications: in vivo studies[J]. J Biomed Mater Res Part B Appl Biomater, 2013, 101(6):972-980.
[15] Kim TH, Yun YP, Park YE, et al.In vitro and in vivo evaluation of bone formation using solid freeform fabrication-based bone morphogenic protein-2 relea-sing PCL/PLGA scaffolds[J]. Biomed Mater, 2014, 9(2):025008.
[16] Sun W, Starly B, Darling A, et al.Computer-aided tissue engineering: application to biomimetic model-ling and design of tissue scaffolds[J]. Biotechnol Appl Biochem, 2004, 39(Pt 1):49-58.
[17] Butscher A, Bohner M, Hofmann S, et al.Structural and material approaches to bone tissue engineering in powder-based three-dimensional printing[J]. Acta Biomater, 2011, 7(3):907-920.
[18] Will J, Melcher R, Treul C, et al.Porous ceramic bone scaffolds for vascularized bone tissue regenera-tion[J]. J Mater Sci Mater Med, 2008, 19(8):2781-2790.
[19] Karageorgiou V, Kaplan D.Porosity of 3D biomate-rial scaffolds and osteogenesis[J]. Biomaterials, 2005, 26(27):5474-5491.
[20] Zambonin G, Camerino C, Greco G, et al.Hydroxya-patite coated with heaptocyte growth factor (HGF) stimulates human osteoblasts in vitro[J]. J Bone Joint Surg Br, 2000, 82(3):457-460.
[21] Hossain M, Irwin R, Baumann MJ, et al.Hepatocyte growth factor (HGF) adsorption kinetics and enhance-ment of osteoblast differentiation on hydroxyapatite surfaces[J]. Biomaterials, 2005, 26(15):2595-2602.
[22] Koempel JA, Patt BS, O’Grady K, et al. The effect of recombinant human bone morphogenetic protein-2 on the integration of porous hydroxyapatite implants with bone[J]. J Biomed Mater Res, 1998, 41(3):359-363.
[23] Takahashi T, Tominaga T, Watabe N, et al.Use of porous hydroxyapatite graft containing recombinant human bone morphogenetic protein-2 for cervical fusion in a caprine model[J]. J Neurosurg, 1999, 90(2 Suppl): 224-230.
[24] Crouzier T, Sailhan F, Becquart P, et al.The perfor-mance of BMP-2 loaded TCP/HAP porous ceramics with a polyelectrolyte multilayer film coating[J]. Bio-materials, 2011, 32(30):7543-7554.
[25] Quinlan E, López-Noriega A, Thompson E, et al.Development of collagen-hydroxyapatite scaffolds incorporating PLGA and alginate microparticles for the controlled delivery of rhBMP-2 for bone tissue engineering[J]. J Control Release, 2015, 198:71-79.
[26] Polak SJ, Levengood SK, Wheeler MB, et al.Analy-sis of the roles of microporosity and BMP-2 on mul-tiple measures of bone regeneration and healing in calcium phosphate scaffolds[J]. Acta Biomater, 2011, 7(4):1760-1771.
[27] 姜蔚然, 张晓, 刘云松, 等. 骨形态发生蛋白-2-磷酸钙共沉淀支架与人脂肪间充质干细胞构建新型组织工程化骨[J]. 北京大学学报(医学版), 2017, 49(1):6-15.
Jiang WR, Zhang X, Liu YS, et al.A novel tissue-engineered bone constructed by using human adipose-derived stem cells and biomimetic calcium phosphate scaffold coprecipitated with bone morphogenetic protein-2[J]. J Peking Univ (Health Sci), 2017, 49(1):6-15.
[28] Roldán JC, Detsch R, Schaefer S, et al.Bone forma-tion and degradation of a highly porous biphasic cal-cium phosphate ceramic in presence of BMP-7, VEGF and mesenchymal stem cells in an ectopic mouse model[J]. J Craniomaxillofac Surg, 2010, 38(6):423-430.
[29] Ossipov DA.Bisphosphonate-modified biomaterials for drug delivery and bone tissue engineering[J]. Expert Opin Drug Deliv, 2015, 12(9):1443-1458.
[30] Son JS, Kwon TY, Kim KH.Osteogenic evaluation of porous calcium phosphate granules with drug de-livery system using nanoparticle carriers[J]. J Nanosci Nanotechnol, 2015, 15(1):130-133.
[31] Ginebra MP, Canal C, Espanol M, et al.Calcium pho-sphate cements as drug delivery materials[J]. Adv Drug Deliv Rev, 2012, 64(12):1090-1110.
[32] Kundu B, Soundrapandian C, Nandi SK, et al.Deve-lopment of new localized drug delivery system based on ceftriaxone-sulbactam composite drug impregnated porous hydroxyapatite: a systematic approach for in vitro and in vivo animal trial[J]. Pharm Res, 2010, 27(8):1659-1676.
[33] Jun W, Lin L, Yurong C, et al.Recent advances of calcium phosphate nanoparticles for controlled drug delivery[J]. Mini Rev Med Chem, 2013, 13(10):1501-1507.
[34] Yoshida K, Bessho K, Fujimura K, et al.Enhancement by recombinant human bone morphogenetic protein-2 of bone formation by means of porous hydroxyapatite in mandibular bone defects[J]. J Dent Res, 1999, 78(9):1505-1510.
[35] Xue W, Bandyopadhyay A, Bose S.Polycaprolactone coated porous tricalcium phosphate scaffolds for con-trolled release of protein for tissue engineering[J]. J Biomed Mater Res Part B Appl Biomater, 2009, 91(2):831-838.
[36] Sadiasa A, Kim MS, Lee BT.Poly(lactide-co-glycolide acid)/biphasic calcium phosphate composite coating on a porous scaffold to deliver simvastatin for bone tissue engineering[J]. J Drug Target, 2013, 21(8):719-729.
[37] Takahashi T.Improved therapeutic efficacy in bone and joint disorders by targeted drug delivery to bone[J]. Yakugaku Zasshi, 2016, 136(11):1501-1508.
[1] Chang Xinnan,Liu Lei. Applications and research progress of biodegradable magnesium-based materials in craniomaxillofacial surgery [J]. Int J Stomatol, 2024, 51(1): 107-115.
[2] Chen Runzhi,Zhang Wentao,Chen Feng,Yang Fan. Modification of silk fibroin-based hydrogels and their applications for bone tissue engineering [J]. Int J Stomatol, 2023, 50(6): 739-746.
[3] Zhou Yi,Zhao Yuming. Research progress on various dental pulp regeneration scaffolds [J]. Int J Stomatol, 2022, 49(1): 19-26.
[4] Gong Jinglei,Huang Yanmei,Wang Jun. Research progress on multiphasic scaffold in periodontal regeneration [J]. Int J Stomatol, 2021, 48(5): 563-569.
[5] Li Peiyi,Zhang Xinchun. Research progress on the effects of microenvironment acid-base level in tissue-engineered bone regeneration [J]. Int J Stomatol, 2021, 48(1): 64-70.
[6] Liu Yuhao,Zhang Tao. Research progress on shape memory polymers in bone defect repair and regeneration [J]. Int J Stomatol, 2020, 47(2): 219-224.
[7] Zou Jundong,Liu Dingkun,Yang Nan,Wang Mi,Liu Zhihui. An overview of bioactive glasses/chitosan composites for biomedical applications [J]. Int J Stomatol, 2020, 47(1): 90-94.
[8] Fang Yi,Siren Wang,Yanhao Chu,Yanqin. Lu. Research progress on the repair of alveolar cleft with bone tissue engineering scaffolds [J]. Inter J Stomatol, 2018, 45(5): 603-610.
[9] Zhou Jie, Wang Ying, Zhang Lei, Wu Tingting, Zhou Yong, Zou Duohong. Characteristics of dental tissue-derived stem cells and their application in bone tissue engineering [J]. Inter J Stomatol, 2018, 45(3): 280-285.
[10] Liang Xinyu, Shi Jiabo, Chen Wenchuan, Zhu Zhimin. Research progress on synthetic nanosilicates in bone tissue engineering [J]. Inter J Stomatol, 2018, 45(3): 340-345.
[11] Zhang Jia, Liu Zhonghao. Research progress on strontium in bone tissue engineering [J]. Inter J Stomatol, 2018, 45(1): 50-54.
[12] Zheng Jianmao, Mao Xueli, Ling Junqi.. Research progress on the Mg-based material scaffolds and its application in animal bone tissue engineering [J]. Int J Stomatol, 2015, 42(6): 720-723.
[13] Si Jiawen1, Guo Lihe2, Shen Guofang1. Biological characteristics and osteogenic differentiation of amniotic epithelial cells [J]. Inter J Stomatol, 2014, 41(5): 575-578.
[14] Tang Yuxin1, Jin Han1, Shi Ce1, Zhu Yang1, Wang Dandan1, Wang He1, Lin Chongtao2, Sun Hongchen1.. Adipose-derived stem cells and their importance to the regulatory mechanism of osteoblast differentiation [J]. Inter J Stomatol, 2014, 41(4): 418-423.
[15] Yang Junjun1,2, Cheng Zhigang2, Song Guangtai1.. Application of the dental drug delivery system in stomatology [J]. Inter J Stomatol, 2014, 41(2): 236-239.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[2] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[3] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[4] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[5] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[6] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[7] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[8] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[9] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[10] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .